The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression
Open accessAbstract
Breast cancer resistance protein (BCRP)/ATP-binding cassette subfamily G member 2 (ABCG2) is an ATP-binding cassette (ABC) transporter identified as a molecular cause of multidrug resistance (MDR) in diverse cancer cells. BCRP physiologically functions as a part of a self-defense mechanism for the organism; it enhances elimination of toxic xenobiotic substances and harmful agents in the gut and biliary tract, as well as through the blood-brain, placental, and possibly blood-testis barriers. BCRP recognizes and transports numerous anticancer drugs including conventional chemotherapeutic and targeted small therapeutic molecules relatively new in clinical use. Thus, BCRP expression in cancer cells directly causes MDR by active efflux of anticancer drugs. Because BCRP is also known to be a stem cell marker, its expression in cancer cells could be a manifestation of metabolic and signaling pathways that confer multiple mechanisms of drug resistance, self-renewal (stemness), and invasiveness (aggressiveness), and thereby impart a poor prognosis. Therefore, blocking BCRP-mediated active efflux may provide a therapeutic benefit for cancers. Delineating the precise molecular mechanisms for BCRP gene expression may lead to identification of a novel molecular target to modulate BCRP-mediated MDR. Current evidence suggests that BCRP gene transcription is regulated by a number of trans-acting elements including hypoxia inducible factor 1α, estrogen receptor, and peroxisome proliferator-activated receptor. Furthermore, alternative promoter usage, demethylation of the BCRP promoter, and histone modification are likely associated with drug-induced BCRP overexpression in cancer cells. Finally, PI3K/AKT signaling may play a critical role in modulating BCRP function under a variety of conditions. These biological events seem involved in a complicated manner. Untangling the events would be an essential first step to developing a method to modulate BCRP function to aid patients with cancer. This review will present a synopsis of the impact of BCRP-mediated MDR in cancer cells, and the molecular mechanisms of acquired MDR currently postulated in a variety of human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1797 · Cited by 2,903
Wilhelm, S. M., Adnane, L., Newell, P., Villanueva, A., Llovet, J. M., & Lynch, M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0013 · Cited by 1,459
Faivre, S., Delbaldo, C., Vera, K., Robert, C., Lozahic, S., Lassau, N., Bello, C., Deprimo, S., Brega, N., Massimini, G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2194 · Cited by 1,164
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
Austin Doyle, L., & Ross, D. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206938 · Cited by 1,051
Self-citationMiyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 929
Allikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 918
Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Woodward, O. M., Köttgen, A., Coresh, J., Boerwinkle, E., Guggino, W. B., & Köttgen, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901249106 · Cited by 688
The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme
Krishnamurthy, P., Ross, D. D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K. E., Sarkadi, B., Sorrentino, B. P., & Schuetz, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313599200 · Cited by 661
Self-citationCharacterization of a Side Population of Cancer Cells from Human Gastrointestinal System
Haraguchi, N., Utsunomiya, T., Inoue, H., Tanaka, F., Mimori, K., Barnard, G. F., & Mori, M. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0282 · Cited by 569
Rabindran, S. K., Ross, D. D., Doyle, L. A., Yang, W., & Greenberger, L. M. (2000) · PubMed · Cited by 487
Self-citationOverexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.
Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C., Ruevekamp, M. C., Floot, B. G., & Schellens, J. H. M. (1999) · PubMed · Cited by 487
Golas, J. M., Arndt, K. T., Etienne, C., Lucas, J., Nardin, D., Gibbons, J. J., Frost, P., Ye, F., Boschelli, D. H., & Boschelli, F. (2003) · PubMed · Cited by 457
Imai, Y., Nakane, M., Kage, K., Tsukahara, S., Ishikawa, E., Tsuruo, T., Miki, Y., & Sugimoto, Y. (2002) · PubMed · Cited by 442
Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Pérez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M. C., & Bates, S. E. (2001) · PubMed · Cited by 429
Localisation of breast cancer resistance protein in microvessel endothelium of human brain
Cooray, H. C., Blackmore, C. G., Maskell, L., & Barrand, M. A. (2002) · NeuroReport · doi:10.1097/00001756-200211150-00014 · Cited by 419
Burger, H., van Tol, H., Boersma, A. W. M., Brok, M., Wiemer, E. A. C., Stoter, G., & Nooter, K. (2004) · Blood · doi:10.1182/blood-2004-04-1398 · Cited by 417
Higgins, C. F. (1995) · Cell · doi:10.1016/0092-8674(95)90465-4 · Cited by 372
Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition
Robey, R. W., Steadman, K., Polgar, O., Morisaki, K., Blayney, M., Mistry, P., & Bates, S. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3298 · Cited by 350
Robey, R. W., Medina-Pérez, W. Y., Nishiyama, K., Lahusen, T. J., Miyake, K., Litman, T., Senderowicz, A. M., Ross, D. D., & Bates, S. E. (2001) · PubMed · Cited by 341
Self-citationABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics
Suzuki, M., Suzuki, H., Sugimoto, Y., & Sugiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212399200 · Cited by 341
Multipotent Stem Cells in Human Corneal Stroma
Du, Y., Funderburgh, M. L., Mann, M. M., SundarRaj, N., & Funderburgh, J. L. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0256 · Cited by 335
Functional Characterization of the Human Multidrug Transporter, ABCG2, Expressed in Insect Cells
Özvegy, C., Litman, T., Szakács, G., Nagy, Z., Bates, S., Váradi, A., & Sarkadi, B. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5130 · Cited by 319
Mizuarai, S., Aozasa, N., & Kotani, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.11669 · Cited by 318
Chen, Z., Robey, R. W., Belinsky, M. G., Shchaveleva, I., Ren, X. Q., Sugimoto, Y., Ross, D. D., Bates, S. E., & Kruh, G. D. (2003) · PubMed · Cited by 305
Self-citationRabindran, S. K., He, H., Singh, M. S., Brown, E., Collins, K., Annable, T., & Greenberger, L. M. (1998) · PubMed · Cited by 305
Functional and molecular characterisation of mammary side population cells
Alvi, A. J., Clayton, H., Joshi, C., Enver, T., Ashworth, A., Vivanco, M. A. M., Dale, T. C., & Smalley, M. J. (2002) · Breast Cancer Research · doi:10.1186/bcr547 · Cited by 289
Side population cells and Bcrp1 expression in lung
Summer, R., Kotton, D. N., Sun, X., Ma, B., Fitzsimmons, K., & Fine, A. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00009.2003 · Cited by 275
Zamber, C. P., Lamba, J. K., Yasuda, K., Farnum, J., Thummel, K., Schuetz, J. D., & Schuetz, E. G. (2003) · Pharmacogenetics · doi:10.1097/00008571-200301000-00004 · Cited by 272
van Herwaarden, A. E., Jonker, J. W., Wagenaar, E., Brinkhuis, R. F., Schellens, J. H. M., Beijnen, J. H., & Schinkel, A. H. (2003) · PubMed · Cited by 269
Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin
Hirano, M., Maeda, K., Matsushima, S., Nozaki, Y., Kusuhara, H., & Sugiyama, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014019 · Cited by 256
Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
Ross, D. D., Karp, J. E., Chen, T. T., & Doyle, L. A. (2000) · Blood · doi:10.1182/blood.v96.1.365 · Cited by 250
Self-citationOverexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.
Volk, E. L., Farley, K. M., Wu, Y. F., Li, F., Robey, R. W., & Schneider, E. (2002) · PubMed · Cited by 248
A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2)
Robey, R. W., Honjo, Y., van de Laar, A., Miyake, K., Regis, J. T., Litman, T., & Bates, S. E. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00308-x · Cited by 245
Breast Cancer Resistance Protein Exports Sulfated Estrogens but Not Free Estrogens
Imai, Y., Asada, S., Tsukahara, S., Ishikawa, E., Tsuruo, T., & Sugimoto, Y. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.610 · Cited by 235
Elkind, N. B., Szentpétery, Z., Apáti, A., Özvegy-Laczka, C., Várady, G., Ujhelly, O., Szabó, K., Homolya, L., Váradi, A., Buday, L., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3303 · Cited by 225
ABCG2: structure, function and role in drug response
Polgar, O., Robey, R. W., & Bates, S. E. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.1.1 · Cited by 224
Erlichman, C., Boerner, S. A., Hallgren, C. G., Spieker, R. S., Wang, X., James, C. D., Scheffer, G. L., Maliepaard, M., Ross, D. D., Bible, K. C., et al. (2001) · PubMed · Cited by 224
Self-citationAllen, J. D., & Schinkel, A. H. (2002) · PubMed · Cited by 218
Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.
Volk, E. L., & Schneider, E. (2003) · PubMed · Cited by 215
Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications
Hiwase, D. K., Saunders, V., Hewett, D., Frede, A., Zrim, S., Dang, P., Eadie, L., To, L. B., Melo, J., Kumar, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5095 · Cited by 208
Burger, H., van Tol, H., Brok, M., Wiemer, E. A. C., de Bruijn, E. A., Guetens, G., de Boeck, G., Sparreboom, A., Verweij, J., & Nooter, K. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.7.1826 · Cited by 207
Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens
(2001) · Current Topics in Cellular Regulation · doi:10.1016/s0070-2137(01)80009-1 · Cited by 203
Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice
Stewart, C. F., Leggas, M., Schuetz, J. D., Panetta, J. C., Cheshire, P. J., Peterson, J., Daw, N., Jenkins, J. J., Gilbertson, R., Germain, G. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0096 · Cited by 203
Singh, A., Wu, H., Zhang, P., Happel, C., Ma, J., & Biswal, S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0108 · Cited by 192
Li, J., Cusatis, G., Brahmer, J., Sparreboom, A., Robey, R. W., Bates, S. E., Hidalgo, M., & Baker, S. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.3.3763 · Cited by 191
ABCG2 expression, function, and promoter methylation in human multiple myeloma
Turner, J. G., Gump, J. L., Zhang, C., Cook, J. M., Marchion, D., Hazlehurst, L., Munster, P., Schell, M. J., Dalton, W. S., & Sullivan, D. M. (2006) · Blood · doi:10.1182/blood-2005-10-009084 · Cited by 189
Evseenko, D. A., Paxton, J. W., & Keelan, J. A. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011478 · Cited by 177
van den Heuvel-Eibrink, M., Wiemer, E., Prins, A., Meijerink, J., Vossebeld, P., van der Holt, B., Pieters, R., & Sonneveld, P. (2002) · Leukemia · doi:10.1038/sj.leu.2402496 · Cited by 175
Yamasaki, Y., Ieiri, I., Kusuhara, H., Sasaki, T., Kimura, M., Tabuchi, H., Ando, Y., Irie, S., Ware, J., Nakai, Y., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100459 · Cited by 167
To, K. K. W., Zhan, Z., Litman, T., & Bates, S. E. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00331-08 · Cited by 164
Akt Signaling Regulates Side Population Cell Phenotype via Bcrp1 Translocation
Mogi, M., Yang, J., Lambert, J.-F., Colvin, G. A., Shiojima, I., Skurk, C., Summer, R., Fine, A., Quesenberry, P. J., & Walsh, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306362200 · Cited by 161
Janvilisri, T., Venter, H., Shahi, S., Reuter, G., Balakrishnan, L., & van Veen, H. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301358200 · Cited by 158
Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate
Jordanides, N. E., Jorgensen, H. G., Holyoake, T. L., & Mountford, J. C. (2006) · Blood · doi:10.1182/blood-2006-02-003145 · Cited by 158
A Conserved Downstream Element Defines a New Class of RNA Polymerase II Promoters
Ince, T. A., & Scotto, K. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30249 · Cited by 157
Shi, G., Xu, Y., Fan, J., Zhou, J., Yang, X., Qiu, S., Liao, Y., Wu, W., Ji, Y., Ke, A., et al. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0407-1 · Cited by 156
MicroRNAs play a role in the development of human hematopoietic stem cells
Liao, R., Sun, J.-G., Zhang, L., Lou, G., Chen, M., Zhou, D.-J., Chen, Z.-T., & Zhang, S. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21668 · Cited by 154
Tan, K. P., Wang, B., Yang, M., Boutros, P. C., MacAulay, J., Xu, H., Chuang, A. I., Kosuge, K., Yamamoto, M., Takahashi, S., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065078 · Cited by 139
Self-citationvan der Kolk, D. M., Vellenga, E., Scheffer, G. L., Müller, M. M., Bates, S. E., Scheper, R. J., & de Vries, E. G. E. (2002) · Blood · doi:10.1182/blood.v99.10.3763 · Cited by 133
Damiani, D., Tiribelli, M., Calistri, E., Geromin, A., Chiarvesio, A., Michelutti, A., Cavallin, M., & Fanin, R. (2006) · PubMed · Cited by 125
Low levels of ABCG2 expression in adult AML blast samples
Abbott, B. L., Colapietro, A.-M., Barnes, Y., Marini, F. C., Andreeff, M., & Sorrentino, B. P. (2002) · Blood · doi:10.1182/blood-2002-01-0271 · Cited by 121
Wang, H., Lee, E., Zhou, L., Leung, P. C. K., Ross, D. D., Unadkat, J. D., & Mao, Q. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041087 · Cited by 116
Self-citationTakada, T., Suzuki, H., Gotoh, Y., & Sugiyama, Y. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003228 · Cited by 113
Allen, J. D., Dort, S. C. V., Buitelaar, M., van Tellingen, O., & Schinkel, A. H. (2003) · PubMed · Cited by 113
Schellens, J. H. M., Maliepaard, M., Scheper, R. J., Scheffer, G. L., Jonker, J. W., Smit, J. W., Beijnen, J. H., & Schinkel, A. H. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb07037.x · Cited by 111
Sugimoto, Y., Tsukahara, S., Imai, Y., Sugimoto, Y., Ueda, K., & Tsuruo, T. (2003) · PubMed · Cited by 110
Expression and functional analyses of breast cancer resistance protein in lung cancer.
Kawabata, S., Oka, M., Soda, H., Shiozawa, K., Nakatomi, K., Tsurutani, J., Nakamura, Y., Doi, S., Kitazaki, T., Sugahara, K., et al. (2003) · PubMed · Cited by 107
Hauswald, S., Duque‐Afonso, J., Wagner, M. M., Schertl, F. M., Lübbert, M., Peschel, C., Keller, U. B., & Licht, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2048 · Cited by 107
WANG, Y., Li, F., LUO, B., Wang, X., Sun, H., LIU, S., Cui, Y., & Xu, X. (2009) · Neoplasma · doi:10.4149/neo_2009_05_371 · Cited by 106
Davies, A., Jordanides, N. E., Giannoudis, A., Lucas, C., Hatziieremia, S., Harris, R. J., Jørgensen, H. G., Holyoake, T. L., Pirmohamed, M., Clark, R. E., et al. (2009) · Leukemia · doi:10.1038/leu.2009.166 · Cited by 106
Raaijmakers, M. H. G. P., de Grouw, E. P. L. M., Heuver, L. H. H., van der Reijden, B. A., Jansen, J. H., Scheper, R. J., Scheffer, G. L., de Witte, T. J. M., & Raymakers, R. A. P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0212 · Cited by 106
Cellular and Molecular Regulation of Skeletal Muscle Side Population Cells
Meeson, A. P., Hawke, T. J., Graham, S. M., Jiang, N., Elterman, J. B., Hutcheson, K. A., DiMaio, J. M., Gallardo, T. D., & Garry, D. J. (2004) · Stem Cells · doi:10.1634/stemcells.2004-0077 · Cited by 103
Ho, M., Hogge, D. E., & Ling, V. W. T. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2007.11.014 · Cited by 99
Zhu, Q., & M S Center (1994) · PubMed · Cited by 99
Komatani, H., Kotani, H., Hara, Y., Nakagawa, R., Matsumoto, M., Arakawa, H., & Nishimura, S. (2001) · PubMed · Cited by 98
Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia
Sauerbrey, A., Sell, W., Steinbach, D., Voigt, A., & Zintl, F. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03550.x · Cited by 97
Knutsen, T., Rao, V. K., Ried, T., Mickley, L. A., Schneider, E., Miyake, K., Ghadimi, Β. M., Padilla‐Nash, H. M., Pack, S., Greenberger, L. M., et al. (2000) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200001)27:1<110::aid-gcc14>3.3.co;2-w · Cited by 93
Wakabayashi‐Nakao, K., Tamura, A., Furukawa, T., Nakagawa, H., & Ishikawa, T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.008 · Cited by 59
Upregulation of ABCG2 by Romidepsin via the Aryl Hydrocarbon Receptor Pathway
To, K. K. W., Robey, R. W., Zhan, Z., Bangiolo, L., & Bates, S. E. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0270 · Cited by 56
Impact of Breast Cancer Resistance Protein on Cancer Treatment Outcomes
Ross, D. D., & Nakanishi, T. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_12 · Cited by 55
Self-citationDrug transporters as targets for cancer chemotherapy.
Nakanishi, T. (2007) · PubMed · Cited by 50
Self-citationThe role of breast cancer resistance protein in acute lymphoblastic leukemia.
Plasschaert, S. L. A., van der Kolk, D. M., de Bont, E. S. J. M., Kamps, W. A., Morisaki, K., Bates, S. E., Scheffer, G. L., Scheper, R. J., Vellenga, E., & de Vries, E. G. E. (2003) · PubMed · Cited by 49
Perry, J., Ghazaly, E. A., Kitromilidou, C., McGrowder, E. H., Joel, S., & Powles, T. B. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0197 · Cited by 44
Zong, Y., Zhou, S., Fatima, S., & Sorrentino, B. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606314200 · Cited by 37
Ni, Z., Mark, M. E., Cai, X., & Mao, Q. (2010) · PubMed Central · Cited by 32
Tamura, A., Wakabayashi, K., Onishi, Y., Nakagawa, H., Tsuji, M., Matsuda, Y., & Ishikawa, T. (2006) · PubMed · Cited by 21
Isolation and Clonal Characterization of Hematopoietic and Liver Stem Cells
Nakauchi, H. (2004) · Cornea · doi:10.1097/01.ico.0000136664.18129.4f · Cited by 14
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Anti-cancer chalcones: Structural and molecular target perspectives
Mahapatra, D. K., Bharti, S. K., & Asati, V. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.004 · Cited by 495
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
Natarajan, K., Xie, Y., Baer, M. R., & Ross, D. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.002 · Cited by 405
Self-citationThe mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Meta-analytic support vector machine for integrating multiple omics data
Kim, S., Jhong, J.-H., Lee, J., & Koo, J.-Y. (2017) · BioData Mining · doi:10.1186/s13040-017-0126-8 · Cited by 159
Metadata
- Authors
- Nakanishi, T., & Ross, D. D.
- Venue
- Chinese Journal of Cancer
- Published
- 2012-02-05
- Volume
- 31
- Issue
- 2
- Pages
- 73-99
- ISSN
- 1000-467X (ISSN-L)
- 1944-446X
- OpenAlex
- W2082177807
- Cited by
- 301
- References
- 88
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.